# Wockhardt posts ₹107 crore profit, antibiotic business drives turnaround 2026-08-14T02:13:55+00:00 | Business & Economy | Indian Opinion Desk Corroboration: 1 independent outlet Wockhardt returned to profit in the June quarter of FY27, reporting a net profit of ₹107 crore against a loss of ₹108 crore a year earlier. Revenue rose 26 per cent to ₹929 crore, and EBITDA grew 86 per cent to ₹188 crore, driven by its novel antibiotic business. The company launched the Wockhardt Antibiotic Academy to promote antimicrobial resistance awareness and antibiotic stewardship among doctors. Wockhardt says around 10 lakh patients die annually in India from multidrug-resistant infections. ## Coverage - businesstoday.in This story was synthesised by AI from the source linked above. Tags: antibiotics, antimicrobial resistance, pharma, profit turnaround, Wockhardt Canonical: https://indianopinion.org/wockhardt-posts-rs107-crore-profit-antibiotic-business-drives-turnaround/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/wockhardt-posts-rs107-crore-profit-antibiotic-business-drives-turnaround/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes. How this brief was made: an AI model read the report linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/